CIK: 1468308 - Address: C/O Fennec Pharmaceuticals, Inc., Po Box 13628, 68 Tw Alexander Drive, Research Triangle Park, NC 27709
10 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y
11/18/24 17:02
11/18/24
FENCFennec Pharmaceuticals Inc.A1HealthBioPrdBiological Products, (No DiagAndrade RobertNCOCFOM.d392.4501614127D
4/3/24 17:00
4/1/24
FENCFennec Pharmaceuticals Inc.A1HealthBioPrdBiological Products, (No DiagAndrade RobertNCOCFOP00.0001314104D
3/27/24 16:22
3/26/24
FENCFennec Pharmaceuticals Inc.A1HealthBioPrdBiological Products, (No DiagAndrade RobertNCOCFOS-15210.900-14-1392D
3/25/24 19:31
3/25/24
FENCFennec Pharmaceuticals Inc.A1HealthBioPrdBiological Products, (No DiagAndrade RobertNCOCFOS-15411.000-14-12106D
1/5/24 17:24
1/4/24
FENCFennec Pharmaceuticals Inc.A1HealthBioPrdBiological Products, (No DiagAndrade RobertNCOCFOS.m-31610.530-30-20120D
6/30/23 16:21
6/28/23
FENCFennec Pharmaceuticals Inc.A1HealthBioPrdBiological Products, (No DiagAndrade RobertNCOCFOS.dm-2238.930-25-14150D
6/30/23 16:21
6/30/23
FENCFennec Pharmaceuticals Inc.A1HealthBioPrdBiological Products, (No DiagAndrade RobertNCOCFOM.d612.4502520150D
12/30/22 16:42
12/28/22
FENCFennec Pharmaceuticals Inc.A1HealthBioPrdBiological Products, (No DiagAndrade RobertNCOCFOS.m-2119.600-22-13150D
8/17/20 16:06
8/13/20
FENCFennec Pharmaceuticals Inc.A1HealthBioPrdBiological Products, (No DiagAndrade RobertNCOCFOM5991.850324153D
8/17/18 16:33
8/15/18
FENCFennec Pharmaceuticals Inc.A1HealthBioPrdBiological Products, (No DiagAndrade RobertNCOCFOM251.44017New17D

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact